Cable Hill Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$306K Sell
4,612
-3,474
-43% -$287K 0.03% 137
2024
Q4
$696K Sell
8,086
-342
-4% -$37K 0.07% 64
2024
Q3
$1M Buy
8,428
+34
+0.4% +$4.53K 0.1% 47
2024
Q2
$1.2M Buy
+8,394
New +$1.11M 0.13% 34
2023
Q4
Sell
-8,490
Closed -$772K 189
2023
Q3
$772K Buy
8,490
+704
+9% +$62K 0.1% 48
2023
Q2
$630K Sell
7,786
-816
-9% -$66.7K 0.08% 58
2023
Q1
$689K Sell
8,602
-394
-4% -$27.9K 0.11% 51
2022
Q4
$609K Buy
8,996
+2,226
+33% +$131K 0.11% 60
2022
Q3
$337K Buy
+6,770
New +$363K 0.07% 93
2019
Q2
Sell
-3,240
Closed -$85K 508
2019
Q1
$85K Sell
3,240
-54
-2% -$1.33K 0.03% 189
2018
Q4
$76K Hold
3,294
0.03% 184
2018
Q3
$71K Hold
3,294
0.03% 145
2018
Q2
$76K Sell
3,294
-204
-6% -$4.85K 0.03% 141
2018
Q1
$85K Sell
3,498
-50
-1% -$1.31K 0.04% 130
2017
Q4
$97K Buy
3,548
+166
+5% +$4.22K 0.04% 150
2017
Q3
$81K Buy
+3,382
New +$76.4K 0.04% 184
2017
Q2
Sell
-100
Closed -$2K 768
2017
Q1
$2K Hold
100
﹤0.01% 675
2016
Q4
$2K Hold
100
﹤0.01% 656
2016
Q3
$2K Hold
100
﹤0.01% 717
2016
Q2
$3K Hold
100
﹤0.01% 590
2016
Q1
$3K Hold
100
﹤0.01% 555
2015
Q4
$3K Hold
100
﹤0.01% 542
2015
Q3
$3K Sell
100
-184
-65% -$5.21K ﹤0.01% 594
2015
Q2
$8K Sell
284
-150
-35% -$4.22K 0.01% 500
2015
Q1
$12K Sell
434
-284
-40% -$6.54K 0.01% 403
2014
Q4
$15K Buy
+718
New +$16K 0.01% 348

Other funds holding NVO

Cable Hill Partners's NVO Position: Q1 2025 in Review

Cable Hill Partners reduced its Novo Nordisk (NVO) stake by 43% in Q1 2025, selling an estimated $287K and leaving 4,612 shares worth $306K. The position accounts for 0.03% of the portfolio, ranked #137.

Cable Hill Partners first reported a position in NVO in Q4 2014 and has held it in 26 quarters since. The position peaked at $1.2M in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Cable Hill Partners held 4,612 shares of Novo Nordisk worth $306K as of Q1 2025.
  • Cable Hill Partners sold 3,474 Novo Nordisk shares in Q1 2025, an estimated $287K.
  • Novo Nordisk made up 0.03% of Cable Hill Partners's portfolio in Q1 2025, its #137 holding.
  • Cable Hill Partners first reported a position in Novo Nordisk in Q4 2014 and has held it in 26 quarters since.
  • Cable Hill Partners's Novo Nordisk position peaked at $1.2M in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.